| Literature DB >> 30361649 |
Yoshiki Sato1,2, Kenta Yamamoto1,2, Satoshi Horiguchi1,2, Yoshiro Tahara3, Kei Nakai1,2, Shin-Ichiro Kotani1, Fumishige Oseko2, Giuseppe Pezzotti1,4, Toshiro Yamamoto2, Tsunao Kishida1, Narisato Kanamura2, Kazunari Akiyoshi5, Osam Mazda6.
Abstract
Transplantation of engineered three-dimensional (3D) bone tissue may provide therapeutic benefits to patients with various bone diseases. To achieve this goal, appropriate 3D scaffolds and cells are required. In the present study, we devised a novel nanogel tectonic material for artificial 3D scaffold, namely the nanogel-cross-linked porous (NanoCliP)-freeze-dried (FD) gel, and estimated its potential as a 3D scaffold for bone tissue engineering. As the osteoblasts, directly converted osteoblasts (dOBs) were used, because a large number of highly functional osteoblasts could be induced from fibroblasts that can be collected from patients with a minimally invasive procedure. The NanoCliP-FD gel was highly porous, and fibronectin coating of the gel allowed efficient adhesion of the dOBs, so that the cells occupied the almost entire surface of the walls of the pores after culturing for 7 days. The dOBs massively produced calcified bone matrix, and the culture could be continued for at least 28 days. The NanoCliP-FD gel with dOBs remarkably promoted bone regeneration in vivo after having been grafted to bone defect lesions that were artificially created in mice. The present findings suggest that the combination of the NanoCliP-FD gel and dOBs may provide a feasible therapeutic modality for bone diseases.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30361649 PMCID: PMC6202359 DOI: 10.1038/s41598-018-33892-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The NanoCliP-FD gel used in the study. (a) Preparation of the NanoCliP-FD gel. Rhodamine-labeled or non-labeled CHPOA was used to generate rhodamine-labeled and non-labeled NanoCliP-FD gel. (b) Rhodamine-labeled NanoCliP gel, NanoCliP-FD matrix, and NanoCliP-FD gel were prepared as described in (a). The 3D-composited images of the whole and surface of the samples as well as cross-sectional images of the samples were obtained by CLSM.
Figure 2Osteoblasts efficiently adhered to and proliferated on the fibronectin-coated NanoCliP-FD gel. (a) Preparation of NanoCliP-FD gel with dOBs. (b,c) XOL-transduced cells were seeded into rhodamine-labeled NanoCliP-FD gel that had been coated with either RGDC or fibronectin. After culturing for the indicated days, the samples were stained with calcein-AM (b) or phalloidin/Hoechst 33342 (c), and CLSM images at magnifications of objective lenses of x2.5 (upper) and x20 (lower) are shown. (d) XOL-transduced cells were seeded into non-coated (−), RGDC-conjugated, and fibronectin-coated NanoCliP-FD gel. After culturing for the indicated days, cell viability was evaluated by tetrazolium-based assay. Values are means ± SD. N = 3. **p < 0.01 vs. day 1.
Figure 3XOL-transduced cells were successfully converted into dOBs that produced calcified bone matrix in fibronectin-coated NanoCliP-FD gel. (a) RNA was extracted from the HDFs or XOL-transduced cells cultured in fibronectin-coated NanoCliP-FD gel for 14 and 28 days. mRNA levels for the indicated genes were evaluated by real time-RT-PCR. Values are means ± SD. N = 3. **p < 0.01 vs. HDFs. (b,c) Fibronectin-coated NanoCliP-FD gel with HDFs and XOL-transduced cells were cultured for the indicated days and stained with Alizarin red S. Some aliquots of the fibronectin-coated NanoCliP-FD gel were cultured without cell seeding (−). Macroscopic images (b) and relative staining intensities (c) are shown. Values are means ± SD. N = 3. **p < 0.01 vs. cell-free control. (d) Fibronectin-coated NanoCliP-FD gel with HDFs or XOL-transduced cells was cultured as above, and osteoimage assay was performed 21 days later. Confocal LSM images at low (upper) and high (lower) magnifications are shown.
Figure 4Bone healing was facilitated by transplantation of the fibronectin-coated NanoCliP-FD gel with dOBs. Fibronectin-coated NanoCliP-FD gel with HDFs or dOBs was prepared as in Fig. 3, and transplanted into an artificial segmental bone defect lesion that was created at femoral diaphysis in NOG/SCID mice. Control mice were not transplanted (−). Mice were sacrificed 21 days after the surgery. (a,b) µCT images of the femur were acquired. Serial 10-µm slices (top and middle) and 3D reconstructed (bottom) images (a) and %Callus formation (b) are shown. (c) Serial sections of the tissues were stained with H-E (upper) and Alizarin red S (lower). In (a) triangles and arrows represent bone defect lesions and regenerated bone tissue, respectively. In (b), values are means ± SD. N = 3 mice. **p < 0.01 vs. non-transplantation control. In (c), *and +represent regenerated bone tissue and NanoCliP-FD gel, respectively, and arrowheads represent bone defect lesions.